Evidence map›Paper›PMID 40430317›Full record

ArticleMolecules (Basel, Switzerland)2025

Nuclear Magnetic Resonance Analysis Seeking for Metabolic Markers of Hypertension in Human Serum.

Adriana Sousa, Nádia Oliveira, Ricardo Conde, Elisabete Morais, Ana Paula Amaral, Nieves Embade, Oscar Millet, Ignacio Verde

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Adriana SousaHealth Sciences Research Centre (CICS-UBI), University of Beira Interior (UBI), 6200-506 Covilhã, Portugal.ORCID 0000-0002-1480-9279
Nádia OliveiraHealth Sciences Research Centre (CICS-UBI), University of Beira Interior (UBI), 6200-506 Covilhã, Portugal.
Ricardo CondeHealth Sciences Research Centre (CICS-UBI), University of Beira Interior (UBI), 6200-506 Covilhã, Portugal.ORCID 0000-0003-4372-081X
Elisabete MoraisHealth Sciences Research Centre (CICS-UBI), University of Beira Interior (UBI), 6200-506 Covilhã, Portugal.
Ana Paula AmaralHealth Sciences Research Centre (CICS-UBI), University of Beira Interior (UBI), 6200-506 Covilhã, Portugal.ORCID 0000-0003-1887-5027
Nieves EmbadeCenter for Cooperative Research in Biosciences (CIC-BioGUNE), Bizkaia Science and Technology Park, 48160 Derio, Spain.ORCID 0000-0001-9878-3290
Oscar MilletCenter for Cooperative Research in Biosciences (CIC-BioGUNE), Bizkaia Science and Technology Park, 48160 Derio, Spain.ORCID 0000-0001-8748-4105
Ignacio VerdeHealth Sciences Research Centre (CICS-UBI), University of Beira Interior (UBI), 6200-506 Covilhã, Portugal.ORCID 0000-0003-3492-5725

Funding

Comisão Coordenadora da Região Centro" (Portugal) CENTRO-01-0145-FEDER-000013"Fundação para a Ciência e a Tecnologia SFRH/BD/06028/2020, SFRH/BD/148695/2019Fundação para a Ciência e a Tecnologia POCI-COMPETE 2020 Project No. 007491Fundação para a Ciência e a Tecnologia UIDB/00709/2020
6 · The paper itself

Abstract

Hypertension is a highly prevalent medical condition that occurs when blood pressure is too high, which greatly increases the risk of developing other cardiovascular diseases and is generally associated with higher rates of morbidity and mortality. Due to the silent/asymptomatic nature of hypertension, although the methods currently available to diagnose it are easy, they generally do not allow for an early diagnosis and an efficient prognosis to avoid irreversible damage in the medium or long term. In fact, an early diagnosis of hypertension would be crucial to decrease hypertension-associated mortality. Since metabolomics using NMR can provide a global measurement of various serum metabolites, it is very suitable for detecting novel biomarkers. We therefore analyzed serum metabolomic profiles among normotensive and hypertensive elderly individuals by NMR and identified new potential biomarkers for hypertension and associated diseases. We found higher levels of acetate, formate, and glycerol, and lower levels of glutamine, glycine, and sarcosine in individuals with hypertension. Therefore, these metabolites could be used for early diagnosis of hypertension to avoid comorbidities derived from hypertension and associated mortality.

Indexed as

BiomarkersHypertensionMetabolomicsAgedFemaleHumansMagnetic Resonance SpectroscopyMaleMetabolomeMiddle AgedBiomarkersagingbiomarkershypertensionmetabolomicsNMR

Identifiers

PMID40430317
PMCPMC12113710

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.